[1]Patent:US4331817,1982,A
Title: Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.
Journal: Bioorganic & medicinal chemistry letters 20101101
75875-58-0 | 4-(Chloromethyl)benzo[d][1,3]dioxole | AA008P28 | MFCD20622113
74531-15-0 | 4,5-Dimethyl-1,3-thiazole-2-carbaldehyde | AA008PPP | MFCD11044203
7365-45-9 | Hepes | AA008QBJ | MFCD00006158
10570-67-9 | 2,6-Dimethyl-4-iodophenol | AA008QYM | MFCD00094415
103060-53-3 | Daptomycin | AA008R7H | MFCD08282794
118612-00-3 | Dimethylanilinium tetrakis(pentafluorophenyl)borate | AA008RJK | MFCD12913898
103889-86-7 | (S)-Amino-(2-methoxy-phenyl)-acetic acid | AA008RR7 | MFCD06858445
102280-35-3 | BAQUILOPRIM | AA008RZ0 | MFCD00864859
1012-17-5 | 3-(4-Chlorophenyl)-2-methylpropanoic acid | AA008S7X | MFCD08445717
1073353-68-0 | 2-Fluoro-4-trifluoromethylphenylboronic acid, pinacol ester | AA008SFX | MFCD08458187